The Alliance for Clinical Trials in Oncology seeks to reduce the impact of cancer by uniting a broad community of scientists
and clinicians who are committed to the prevention and treatment of cancer.
The Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trials, or ALCHEMIST, is a group of clinical trials for patients with certain types of early-stage non-small cell lung cancer (NSCLC) that has been treated surgically. The ALCHEMIST trials involve genetic screening of tumor specimens removed during surgery for specific gene mutations and testing of adjuvant (post-operative) treatment with drugs that target those mutations but have only been approved by the U.S. Food and
2015 Fall Group Meeting | November 4-8
2016 Fall Group Meeting | November 2-5
2017 Fall Group Meeting | November 1-4
Loews Chicago O'Hare Hotel, Rosemont, IL 60018
open to all Alliance members